scholarly article | Q13442814 |
P50 | author | John M. Freeman | Q18575883 |
Elisabeth B Marsh | Q57565760 | ||
Eric Kossoff | Q90928928 | ||
Eileen P. G. Vining | Q105941162 | ||
Paula L. Pyzik | Q124281563 | ||
P2093 | author name string | Cheryl Hemingway | |
James E Rubenstein | |||
P2860 | cites work | Early identification of refractory epilepsy | Q28144133 |
The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively | Q34093286 | ||
The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children | Q34481820 | ||
Early development of intractable epilepsy in children: a prospective study | Q34515694 | ||
Some aspects of prognosis in the epilepsies: a review | Q40781638 | ||
The impact of new antiepileptic drugs on the prognosis of epilepsy: seizure freedom should be the ultimate goal | Q41089572 | ||
Incidence of epilepsy in childhood and adolescence: a population-based study in Nova Scotia from 1977 to 1985. | Q43768203 | ||
A follow-up study of intractable seizures in childhood | Q43873076 | ||
Remission of seizures and predictors of intractability in long-term follow-up. | Q52222989 | ||
P433 | issue | 2 | |
P304 | page(s) | 425-430 | |
P577 | publication date | 2006-02-01 | |
P1433 | published in | Epilepsia | Q5382969 |
P1476 | title | The outcome of children with intractable seizures: a 3- to 6-year follow-up of 67 children who remained on the ketogenic diet less than one year. | |
P478 | volume | 47 |
Q92058778 | A Journey of Dietary Therapies for Epilepsy in Iran: Diet Restriction in the Ancient Era to the Ketogenic Diet in the Modern Period |
Q38379396 | Epigenetic mechanisms in neurological and neurodegenerative diseases |
Q46008893 | How we treat Bowen's disease with topical photodynamic therapy in Dundee. |
Q22299266 | Ketogenic Diets: An Update for Child Neurologists |
Q33778181 | Ketogenic diet: Predictors of seizure control |
Q34971377 | Ketogenic diets: evidence for short- and long-term efficacy |
Q47855250 | Long-term follow-up of children treated with the modified Atkins diet |
Q24646914 | Neuroprotective and disease-modifying effects of the ketogenic diet |
Q34431317 | Potential therapeutic use of the ketogenic diet in autism spectrum disorders |
Q36739694 | Progress in neuroprotective strategies for preventing epilepsy. |
Q42716720 | The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway |
Q24617926 | The ketogenic diet: uses in epilepsy and other neurologic illnesses |
Q24646616 | The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies |
Q34423682 | Therapeutic Success of the Ketogenic Diet as a Treatment Option for Epilepsy: a Meta-analysis |
Q35028378 | Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis |